Skip to main content
Premium Trial:

Request an Annual Quote

Heed the Warnings

At Inside Higher Ed, Nate Kreuter wonders why some graduate students — even those who have been warned about poor job prospects in academia — seem "incapable of hearing" the bad news. Perhaps, he says, "the very same qualities that lead many graduate students to pursue higher degrees are the qualities that make them incapable of hearing and processing even the most dire warnings about their professional prospects." More specifically, Kreuter says those can make it "impossible for many graduate students to understand … that everybody in their cohort is just as smart and hardworking as they themselves are. At the graduate level, the smarts and diligence that once set students apart from their undergraduate peers will no longer set them apart, but merely allow them to keep up."

Overall, Kreuter says, "the bad academic job market that my cohort was warned about has become the abysmal job market that leads advisers to now say things to their grad students along the lines of 'I don't know. It's always been bad, but it's never been this bad.'" And that, he says, should not be taken lightly.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.